News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

Genetix Group plc (GTX.L) Expands Sales, Support and Service Organization in France and Benelux

12/8/2009 11:37:41 AM

New Milton, Hampshire, UK, 8th December 2009 – Genetix, a leading provider of solutions for imaging and image analysis, announces the expansion of its sales, support and service organization in France and Benelux. This expansion means that scientists working in these regions now have direct local access to dedicated Genetix representatives.

Charles de Rohan, CEO, Genetix, commented: “As many of our leading instruments gain widespread acceptance in the life science markets, we believe that the time is right to enhance our sales activities and the support given to customers in these regions. This decision supports Genetix’ overall business objective through growing our direct presence in major geographies, further developing our customer relationships worldwide."

Fabienne Tardieu has been appointed as Territory Sales Manager to cover France and French-speaking areas in Benelux. Fabienne has over 20 years’ experience working within the life science industry, including holding positions at Millipore and Stratagene.

Jochum de Graaf joins Fabienne to support certain accounts in Belgium, extending his current responsibilities as Business Manager for The Netherlands and the Nordic region.

In France and Benelux the sales teams for Genetix products aimed at the clinical market (CytoVision®) and for the quantification of tissue biomarkers (Ariol®) will remain the same.

Genetix now takes on full responsibility for service and support of the company’s entire product portfolio in these regions.

About Genetix (

Headquartered in New Milton, UK, with offices in the UK, US, Germany and Japan, and quoted on the AIM (GTX: AIM), Genetix provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis in the life science and diagnostic markets.

In research, pharmaceutical and biotherapeutic development, the Company’s systems set industry standards for screening and selection of mammalian secretory cell lines. Other systems evaluate the response of cells to potential therapeutic agents and quantify tissue biomarkers.

In diagnostics, Genetix holds a leading position in genetic testing with thousands of the Company’s platforms used in laboratories worldwide.

Through its expertise in robotics, cell and molecular biology, image analysis and interpretation, supported by a strong IP portfolio, Genetix is committed to the continual development of innovative solutions.

Read at

comments powered by Disqus